SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-4.27%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$501M
AUM Growth
+$105M
(+27%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
29.4%
Top 10 Holdings %
Top 10 Hldgs %
32.77%
Holding
285
New
86
Increased
56
Reduced
45
Closed
28
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$35.7M |
| 2 |
Biogen
BIIB
|
$22.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 4 |
Viatris
VTRS
|
$15.2M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$14.5M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$28.9M |
| 2 |
Merck
MRK
|
$17.9M |
| 3 |
Exxon Mobil
XOM
|
$14.8M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$10M |
| 5 |
Gevo
GEVO
|
$7.38M |
Sector Composition
| 1 | Healthcare | 64.78% |
| 2 | Energy | 5.21% |
| 3 | Technology | 2.24% |
| 4 | Materials | 2.17% |
| 5 | Consumer Discretionary | 0.69% |
